• News
  • SAN DIEGO
  • Health

Neurocrine Biosciences granted two patents

Neurocrine Biosciences Inc. (Nasdaq: NBIX) has announced that two more patents have been granted related to the company's proprietary Vesicular Monoamine Transporter 2 inhibitor.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Neurocrine Biosciences Inc.

Company Website

12790 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
NBIX
19.95
  0.50  
+ 2.57%
449,317,000
20.29
8.87

Insider Trade Data

Date Insider Shares Type Value
11/24/2014 O Brien, Christopher F 5,463 Sell $106,692
11/24/2014 O Brien, Christopher F 5,463 Exchange $14,149
11/17/2014 O Brien, Christopher F 34,537 Exchange $89,451
11/17/2014 O Brien, Christopher F 34,537 Sell $655,985
11/13/2014 O Brien, Christopher F 23,237 Exchange $60,184

Neurocrine Biosciences Inc. Executive(s):

Kevin Gorman

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
Subscribe Today!